Filing Details

Accession Number:
0001213900-25-045163
Form Type:
13G Filing
Publication Date:
2025-05-18 20:00:00
Filed By:
Alpha Capital Anstalt
Company:
Nanovibronix Inc.
Filing Date:
2025-05-19
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Alpha Capital Anstalt 0 82,471 9.99%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Note to 5, 7, 9 and 11: Based on 825,533 shares outstanding as of April 29, 2025 as reported on Form S-1/A filed with the Securities and Exchange Commission on May 14, 2025. Note to 10: The aggregate amount in Row 9 represents the maximum amount of shares that Alpha Capital Anstalt can beneficially control under a contractually stipulated 9.99% ownership restriction. The full conversion and/or exercise of Alpha Capital Anstalt's securities would exceed this restriction.


SCHEDULE 13G


 
Alpha Capital Anstalt
 
Signature:/s/ Konrad Ackermann
Name/Title:Konrad Ackermann/Director
Date:05/19/2025